Reframing Obesity Treatment: Addressing Stigma, Myths, Misconceptions, and Patient Concerns On-Demand-Optimizing Care: Managing Concerns and Improving Adherence

Video Transcription

Video Summary

The "Reframing Obesity Treatment Series" webinar aims to improve obesity care by tackling stigma, myths, and concerns, with a focus on adherence to pharmacotherapy. Key panelists include Dr. Jennifer Clemens, Dr. Jaime Almendros, and Dr. Monisha Chadha. The session emphasizes patient-centered approaches and shared decision-making, particularly in relation to pharmacotherapy for obesity, such as GLP-1 receptor agonists. Discussions also address potential side effects like gastrointestinal issues, muscle mass loss, and barriers to accessing medication.<br /><br />Dr. Clemens opens the discussion with a hypothetical case about managing GI symptoms related to GLP-1 receptor agonists, emphasizing reducing the dose or managing dietary habits to alleviate side effects. Patients are advised to follow the 5 As—Ask, Assess, Advise, Agree, and Assist—albeit with updated, more collaborative terminology. Comprehensive obesity care also involves pillars like nutrition and behavioral modifications.<br /><br />Case studies highlight the importance of personalized care and support in medication adherence and side effect management. Key strategies mentioned include educating patients on potential side effects, gradually escalating doses, and adjusting lifestyle recommendations, like portion size and protein intake.<br /><br />The panel also discusses the cost and accessibility issues of obesity treatments, advising documentation and appeals to insurers to overcome barriers. Despite safety concerns like pancreatitis and gallbladder disease, evidence generally supports the tolerability of these medications.<br /><br />Overall, the webinar underscores the significance of individualized care, patient education, and careful monitoring to optimize treatment outcomes for obesity while addressing barriers related to cost and medication access.

Keywords

obesity treatment

stigma

pharmacotherapy

GLP-1 receptor agonists

patient-centered care

side effects

medication adherence

accessibility issues

personalized care

nutrition